POLITICO @politico
Drugmakers and patient advocacy groups are waging a campaign to cast Medicare officials as villains after the program limited coverage of a pricey new Alzheimer’s drug and demanded tougher criteria than the FDA to prove it works https://t.co/JrrutqWwiA — PolitiTweet.org
